1. Adelaide Research & Scholarship

Search


Current filters:

Start a new search
Add filters:

Use filters to refine the search results.

 | 
Results 1-10 of 12 (Search time: 0.004 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2016A whey/guar "preload" improves postprandial glycaemia and HbA(1c) in type 2 diabetes: a 12-week, single-blind, randomised and placebo controlled trialMignone, L.; Wu, T.; Phillips, L.; Bound, M.; Checklin, H.; Grivell, J.; Jones, K.; Clifton, P.; Horowitz, M.; Rayner, C.; 52nd Annual Meeting of the European Association for the Study of Diabetes (EASD) (12 Sep 2016 - 16 Sep 2016 : Munich, GERMANY)
2017Longitudinal evaluation of gastric emptying in type 2 diabetesPhillips, L.; Watson, L.; Wu, T.; Bound, M.; Checklin, H.; Grivell, J.; Jones, K.; Horowitz, M.; Rayner, C.; 53rd Annual Meeting of the European Association for the Study of Diabetes (EASD 2017) (11 Sep 2017 - 15 Sep 2017 : Lisbon, PORTUGAL)
2014Small intestinal glucose exposure determines the magnitude of the incretin effect in health and type 2 diabetesMarathe, C.; Rayner, C.; Bound, M.; Checklin, H.; Standfield, S.; Wishart, J.; Lange, K.; Jones, K.; Horowitz, M.
2014Effects of sitagliptin on glycemia, incretin hormones, and antropyloroduodenal motility in response to intraduodenal glucose infusion in healthy lean and obese humans and patients with type 2 diabetes treated with or without metforminWu, T.; Ma, J.; Bound, M.; Checklin, H.; Deacon, C.; Jones, K.; Horowitz, M.; Rayner, C.
2014Changes in meal composition and duration affect postprandial endothelial function in healthy humansThazhath, S.; Wu, T.; Bound, M.; Checklin, H.; Jones, K.; Willoughby, S.; Horowitz, M.; Rayner, C.
2016Effects of intraduodenal hydroxycitrate on glucose absorption, incretin release, and glycemia in response to intraduodenal glucose infusion in health and type 2 diabetes: a randomised controlled trialThazhath, S.; Wu, T.; Bound, M.; Checklin, H.; Standfield, S.; Jones, K.; Horowitz, M.; Rayner, C.
2016The glucagon-like peptide 1 receptor agonist exenatide inhibits small intestinal motility, flow, transit, and absorption of glucose in healthy subjects and patients with type 2 diabetes: a randomized controlled trialThazhath, S.; Marathe, C.; Wu, T.; Chang, J.; Khoo, J.; Kuo, P.; Checklin, H.; Bound, M.; Rigda, R.; Crouch, B.; Jones, K.; Horowitz, M.; Rayner, C.
2016Effect of duodenal glucose load on blood pressure in type 2 diabetesMarathe, C.; Horowitz, M.; Trahair, L.; Bound, M.; Checklin, H.; Lange, K.; Rayner, C.; Jones, K.
2016Administration of resveratrol for 5 wk has no effect on glucagon-like peptide 1 secretion, gastric emptying, or glycemic control in type 2 diabetes: a randomized controlled trialThazhath, S.; Wu, T.; Bound, M.; Checklin, H.; Standfield, S.; Jones, K.; Horowitz, M.; Rayner, C.
2013A randomised trial of enteric-coated nutrient pellets to stimulate gastrointestinal peptide release and lower glycaemia in type 2 diabetesMa, J.; Checklin, H.; Wishart, J.; Stevens, J.; Jones, K.; Horowitz, M.; Meyer, J.; Rayner, C.

Discover